Retrospective Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. Feb 7, 2020; 26(5): 524-534
Published online Feb 7, 2020. doi: 10.3748/wjg.v26.i5.524
Table 1 Patient baseline characteristics
Characteristicn (%)/mean ± SD
Male/female738/264 (73.65/26.35)
Age at diagnosis (yr)28.41 ± 11.05
Drinking/not drinking58/944 (5.79/94.21)
Smoking/not smoking150/852 (14.97/85.03)
Body mass index at diagnosis (kg/m2)18.58 ± 2.90
Year of follow-up (mo)53.54 ± 13.10
Montreal classification
Age at diagnosis (%)
A1119 (11.88)
A2744 (74.25)
A3139 (13.87)
Location at diagnosis
L1145 (14.47)
L2104 (10.38)
L3678 (67.66)
L475 (7.49)
Behavior at diagnosis
B1614 (61.28)
B2185 (18.46)
B3203 (20.26)
CRP at diagnosis19.84 ± 24.25
ESR at diagnosis34.58 ± 28.48
Alb at diagnosis39.14 ± 25.65
Previous perianal surgery299 (29.84)
Previous intestinal surgery409 (40.82)
Complication287 (28.64)
Stenosis129 (12.87)
Perforation139 (13.87)
GI bleeding19 (1.90)
Treatment
5-aminosalicylic acid202 (20.16)
Immunosuppressants746 (74.45)
Corticosteroids529 (52.79)
Biologics462 (46.11)
EEN230 (22.95)
Surgery within 1 yr after diagnosis243(24.25)
Surgery within the follow-up period473 (47.21)
Table 2 Factors associated with possibility of one-year surgery in patients with Crohn’s disease
FactorUnivariate analysis
Multivariable logistic regression
OR95%CIPOR95%CIP
Gender (male vs female)0.7930.565-1.1130.180
Age (yr)1.0120.999-1.0250.070
Location (L1 vs L2/L3/L4)
L20.7290.401-1.3240.300
L30.8530.568-1.2820.445
L40.9880.526-1.8550.971
Behavior (B1 vs B2/B3)
B25.7713.837-8.680< 0.0016.6933.437-13.032< 0.001
B314.99810.113-22.242< 0.00114.4057.208-28.790< 0.001
Maximum BWT1.3911.278-1.514< 0.0011.9651.660-2.327< 0.001
Drinking1.7020.970-2.9850.064
Smoking4.3593.034-6.262< 0.0014.1352.149-7.953< 0.001
BMI0.9010.854-0.950< 0.0010.8730.786-0.9680.01
Previous perianal surgery6.7764.943-9.288< 0.0019.4835.317-16.912< 0.001
Previous intestinal surgery5.1993.794-7.125< 0.0018.8875.045-15.656< 0.001
5-aminosalicylic acid use0.7090.485-1.0380.077
Immunosuppressants use0.9740.700-1.3550.877
Corticosteroid use0.9310.697-1.2430.627
Biologics use0.2830.204-0.392< 0.0010.2640.146-0.476< 0.001
Exclusive enteral nutrition use0.3590.235-0.550< 0.0010.0890.038-0.205< 0.001
CRP at diagnosis (pathological vs normal)1.0201.014-1.026< 0.0011.0221.009-1.0360.001
ESR at diagnosis (pathological vs normal)1.0051.000-1.0100.058
Alb at diagnosis (pathological vs normal)0.9810.962-1.0010.058